Search research articles
Contact Us
Filters
Showing results (111-120 of 539) with videos related to
Page
of 54
Sort By:
Life Sciences
|
January 1, 1991
Pergolide: a dopamine agonist at both D1 and D2 receptors
R W Fuller, J A Clemens
Journal of Clinical Psychopharmacology
|
December 1, 1987
Serotonin reuptake blockers in vitro and in vivo
R W Fuller, D T Wong
Archives Internationales De Pharmacodynamie Et De Therapie
|
March 1, 1978
Effect of p-chloramphetamine on the inactivation of monoamine oxidase in rat brain by 3-amino-2-oxazolidinone, 2-hydroxyethylhydrazine and pheylisopropylhydrazine
R W Fuller, B W Roush
Neuropharmacology
|
December 1, 1984
Central dopamine receptors mediating pergolide-induced elevation of serum corticosterone in rats. Characterization by the use of antagonists
R W Fuller, H D Snoddy
Biochemical Pharmacology
|
July 15, 1981
Amfonelic acid antagonism of dopamine and norepinephrine depletion by alpha-methyl-m-tyrosine in rat brain
R W Fuller, K W Perry
Life Sciences
|
May 28, 1979
Differences in the effects of amphetamine and methylphenidate on brain dopamine turnover and serum prolactin concentration in reserpine-treated rats
J A Clemens, R W Fuller
Research Communications in Chemical Pathology and Pharmacology
|
August 1, 1974
Further evidence for serotonin involvement in thermoregulation following morphine administration from studies with an inhibitor of serotonin uptake
R W Fuller, J C Baker
Toxicology and Applied Pharmacology
|
April 1, 1975
Inhibition of serotonin uptake and the toxic interaction between meperidine and monoamine oxidase inhibitors
R W Fuller, H D Snoody
Thorax
|
June 1, 1990
Physiology and treatment of cough
R W Fuller, D M Jackson
British Medical Journal (Clinical Research Ed.)
|
October 24, 1987
Increased cough reflex associated with angiotensin converting enzyme inhibitor cough
R W Fuller, N B Choudry
Page
of 54
Search research articles
Search
Showing results (111-120 of 539) with videos related to
Sort By:
Page
of 54
Life Sciences
|
January 1, 1991
Pergolide: a dopamine agonist at both D1 and D2 receptors
R W Fuller, J A Clemens
Journal of Clinical Psychopharmacology
|
December 1, 1987
Serotonin reuptake blockers in vitro and in vivo
R W Fuller, D T Wong
Archives Internationales De Pharmacodynamie Et De Therapie
|
March 1, 1978
Effect of p-chloramphetamine on the inactivation of monoamine oxidase in rat brain by 3-amino-2-oxazolidinone, 2-hydroxyethylhydrazine and pheylisopropylhydrazine
R W Fuller, B W Roush
Neuropharmacology
|
December 1, 1984
Central dopamine receptors mediating pergolide-induced elevation of serum corticosterone in rats. Characterization by the use of antagonists
R W Fuller, H D Snoddy
Biochemical Pharmacology
|
July 15, 1981
Amfonelic acid antagonism of dopamine and norepinephrine depletion by alpha-methyl-m-tyrosine in rat brain
R W Fuller, K W Perry
Life Sciences
|
May 28, 1979
Differences in the effects of amphetamine and methylphenidate on brain dopamine turnover and serum prolactin concentration in reserpine-treated rats
J A Clemens, R W Fuller
Research Communications in Chemical Pathology and Pharmacology
|
August 1, 1974
Further evidence for serotonin involvement in thermoregulation following morphine administration from studies with an inhibitor of serotonin uptake
R W Fuller, J C Baker
Toxicology and Applied Pharmacology
|
April 1, 1975
Inhibition of serotonin uptake and the toxic interaction between meperidine and monoamine oxidase inhibitors
R W Fuller, H D Snoody
Thorax
|
June 1, 1990
Physiology and treatment of cough
R W Fuller, D M Jackson
British Medical Journal (Clinical Research Ed.)
|
October 24, 1987
Increased cough reflex associated with angiotensin converting enzyme inhibitor cough
R W Fuller, N B Choudry
Page
of 54